Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General cellular proteins and lipid membranes represent a broad class of non-specific therapeutic targets primarily utilized by antiseptics, disinfectants, and certain antimicrobial agents. These targets encompass the structural and functional components of both prokaryotic and eukaryotic cells, where drugs exert their effects through physical or chemical disruption rather than specific ligand-receptor interactions (McDonnell & Russell, 1999, Clinical Microbiology Reviews). For proteins, agents like alcohols and aldehydes cause rapid denaturation or covalent cross-linking, leading to the loss of enzymatic activity and structural collapse (StatPearls, "Antiseptics and Disinfectants"). Lipid membranes are targeted by surfactants and lipophilic compounds that intercalate into the bilayer, increasing permeability or causing total lysis, which is a primary mechanism for agents like chlorhexidine and detergents (Gilbert & Moore, 2005, Journal of Applied Microbiology). Because these targets are ubiquitous across all cell types, drugs acting on them typically exhibit a broad spectrum of activity but carry significant risks of host tissue damage, limiting their use to topical applications or sterilization (PubChem, "Ethanol"). Consequently, these targets are primarily exploited in surgical preparation and environmental decontamination to prevent infection (Journal of Hospital Infection, 2004).
The mechanism of action involves the non-specific denaturation of cellular proteins and the physical disruption of the lipid bilayer, leading to loss of membrane potential and leakage of cytoplasmic contents (McDonnell & Russell, 1999, Clinical Microbiology Reviews).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General cellular proteins and lipid membranes.